GlassScriptPhysician profile
Caleb P Mcferren
NPI 1083000483
$4,780.65
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $882 · 2020: $155 · 2021: $142 · 2022: $213 · 2023: $3,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,325 · Food and Beverage: $63.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,325.00 |
| Food and Beverage | $63.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $3,500.75 | 2022-2023 | Fibula Nail, 4.5mm X 180mm, Titanium, Flex-Thread, Zero Profile Interlocking Cortex Screw, 2.7mm X 14mm, T8, Flex-Thread, Fibula Nail, 4.5mm X 130mm, Titanium, Flex-Thread |
| Acumed LLC | $689.36 | 2019 | |
| Stryker Corporation | $126.22 | 2019-2020 | |
| Ortho Solutions INC | $124.28 | 2021 | |
| Kci USA, INC. | $112.22 | 2019 | |
| Misonix INC | $111.56 | 2020-2021 | |
| Conmed Corporation | $37.32 | 2022 | |
| Organogenesis INC. | $36.80 | 2023 | Puraply |
| Amgen INC. | $15.50 | 2019 | |
| Bioventus LLC | $13.75 | 2023 | Theragenesis Bilayer Wound Matrix |
| Cashflow Solutions, LLC | $12.89 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Mcferren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.